Jinling Pharmaceutical Co Ltd (000919) — Financial Flexibility Index
Jinling Pharmaceutical Co Ltd (000919) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of CN¥86.57 Million (operating CF CN¥74.01 Million minus capex CN¥12.56 Million) represents 0% of total liabilities (CN¥1.18 Billion). Check cash flow reinvestment rate of Jinling Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jinling Pharmaceutical Co Ltd Financial Flexibility Index (1999–2024)
Historical Financial Flexibility Index trend for Jinling Pharmaceutical Co Ltd across 26 annual periods. For the full cash flow conversion analysis, see how efficiently does Jinling Pharmaceutical Co Ltd generate cash.
Annual Financial Flexibility Index for Jinling Pharmaceutical Co Ltd (1999–2024)
Year-by-year free cash flow to debt coverage for Jinling Pharmaceutical Co Ltd. Explore Jinling Pharmaceutical Co Ltd (000919) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.29x | CN¥355.82 Million | CN¥154.19 Million | CN¥1.24 Billion | ▼ -28.1% |
| 2023 | 0.40x | CN¥345.18 Million | CN¥158.92 Million | CN¥865.58 Million | ▼ -35.9% |
| 2022 | 0.62x | CN¥570.23 Million | CN¥260.59 Million | CN¥916.30 Million | ▲ +24.9% |
| 2021 | 0.50x | CN¥454.79 Million | CN¥292.03 Million | CN¥913.10 Million | ▼ -29.7% |
| 2020 | 0.71x | CN¥602.87 Million | CN¥311.46 Million | CN¥850.43 Million | ▼ -12.1% |
| 2019 | 0.81x | CN¥591.56 Million | CN¥465.85 Million | CN¥733.62 Million | ▼ -9.7% |
| 2018 | 0.89x | CN¥570.25 Million | CN¥433.83 Million | CN¥638.90 Million | ▲ +40.6% |
| 2017 | 0.63x | CN¥509.90 Million | CN¥443.11 Million | CN¥803.11 Million | ▲ +151.0% |
| 2016 | 0.25x | CN¥203.60 Million | CN¥96.15 Million | CN¥804.90 Million | ▼ -26.1% |
| 2015 | 0.34x | CN¥316.76 Million | CN¥212.45 Million | CN¥925.73 Million | ▼ -23.8% |
| 2014 | 0.45x | CN¥391.03 Million | CN¥299.89 Million | CN¥871.24 Million | ▼ -21.1% |
| 2013 | 0.57x | CN¥415.26 Million | CN¥271.21 Million | CN¥729.94 Million | ▼ -0.9% |
| 2012 | 0.57x | CN¥420.88 Million | CN¥232.12 Million | CN¥733.12 Million | ▲ +42.5% |
| 2011 | 0.40x | CN¥255.03 Million | CN¥172.82 Million | CN¥633.01 Million | ▼ -19.7% |
| 2010 | 0.50x | CN¥273.29 Million | CN¥177.81 Million | CN¥544.47 Million | ▼ -29.5% |
| 2009 | 0.71x | CN¥285.01 Million | CN¥188.41 Million | CN¥400.59 Million | ▼ -29.5% |
| 2008 | 1.01x | CN¥327.38 Million | CN¥305.26 Million | CN¥324.25 Million | ▲ +202.7% |
| 2007 | 0.33x | CN¥139.03 Million | CN¥118.06 Million | CN¥416.86 Million | ▼ -31.8% |
| 2006 | 0.49x | CN¥161.59 Million | CN¥138.50 Million | CN¥330.39 Million | ▼ -6.0% |
| 2005 | 0.52x | CN¥145.90 Million | CN¥109.29 Million | CN¥280.42 Million | ▼ -27.7% |
| 2004 | 0.72x | CN¥232.28 Million | CN¥159.81 Million | CN¥322.83 Million | ▼ -15.7% |
| 2003 | 0.85x | CN¥218.59 Million | CN¥161.86 Million | CN¥256.06 Million | ▲ +8.7% |
| 2002 | 0.79x | CN¥232.99 Million | CN¥130.36 Million | CN¥296.79 Million | ▼ -4.8% |
| 2001 | 0.82x | CN¥252.77 Million | CN¥92.49 Million | CN¥306.54 Million | ▼ -63.6% |
| 2000 | 2.27x | CN¥365.80 Million | CN¥231.31 Million | CN¥161.37 Million | ▲ +212.0% |
| 1999 | 0.73x | CN¥111.34 Million | CN¥39.77 Million | CN¥153.24 Million | — |